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OBJECTIVE: The purpose of this study was to describe the probable mechanism of the volume increase of
laparoscopically harvested omentum flaps used to treat breast deformities.
METHODS: A histological analysis of omentum samples was performed to study the volume increase of
laparoscopically harvested omentum flaps. Samples were harvested immediately after the transposition of the
omentum from the abdominal cavity to the breast region and during the second surgical procedure for breast
symmetrization of eight patients submitted to the transposition of the omentum flap. Changes in the morphometric
measurements of the adipocytes (perimeter, diameter, and area), microvascular density (as measured by the CD31
endothelial marker), and immunohistochemical expression of VEGF were documented.
RESULTS: The increases in adipocyte size and microvascular density were statistically significant (P # 0.012). The
expression levels of VEGF were lower in the second set of samples when compared to the first set, but the
differences were not statistically significant (P , 0.093).
CONCLUSION: These results demonstrate an increase in cellular volume as measured by adipocyte perimeter,
diameter, and area. Moreover, the increase in the number of vessels in the second set of samples suggests that
neoangiogenesis was stimulated by the initial increase in VEGF expression levels observed in the first set of samples.
The increase in VEGF expression in the flap may have been caused by adipocyte hypertrophy resulting from
neoangiogenesis.
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INTRODUCTION
There are numerous reports of tissue volume increase
in human1,2 and animal (rodents, bovines, swine, etc.)3-5
tissues, and in cell cultures.6,7 However, such increases have
never been observed in any other adipose flaps.8,9
The omentum is composed of highly vascularized fatty
connective tissue; it is approximately 25635 cm long, its
volume varies according to the size of the patient but it is
not always predictable.10 The use of the omentum for
various purposes has been reported,8-14 because of its
peculiar structure, its rich vascular supply that enables its
high capacity of absorption, its pronounced angiogenic
activity that supports local (and ischemic) tissues, its innate
immune function, its ability to adhere to local structures and
its high concentration of ‘‘tissue factors’’ that promote
hemostasia.8,11-14 It may promote angiogenic activity in
structures adjacent to where it is applied to in animals15 and
in human beings.11
The omentum is predominantly composed of mature
adipocytes that do not multiply and that represent an
important share of visceral fat in the human body. It
contains adult stem cells and progenitor cells or preadipo-
cytes, which are smaller and able to differentiate.16
Adipocytes are now seen as energy storage cells as well as
cell with endocrine function.17 The observation that they
secrete leptin established that adipose tissue is an endocrine
organ communicating with the central nervous system.18
Hypoxic adipocytes express more angiogenic factors,
suggesting that hypoxia might be one of the modulators of
the angiogenic process.19-21
Zhang et al in 1997, suggested that the vascular
endothelial growth factor (VEGF) is probably the main
angiogenic factor produced by the omentum.3 Increased
VEGF expression by hypoxic omentum cells may be
responsible for increased omentum angiogenic activity
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under ischemic conditions through paracrine regulation.
The trauma of surgically transplanted omentum induces
increased VEGF expression, similar to that induced by
hypoxia.3,5
Adipose tissue growth can be controlled by local
vascularization. Adipocyte development and vascular mor-
phology are dependent on triglyceride deposit whereas
adipocyte size does not depend on storage volume.5
Increased triglyceride induces preadipocytes to become
mature adipocytes with consequent hypertrophy and
hyperplasia. The increase in the bulk of adipocytes is
accompanied by an increase in the microvascular network22
and, conversely, neovascularization accompanies adipose
tissue growth. Evidence suggests that the O2-sensitive
signaling mechanism regulates adipogenesis.19 However,
preadipocyte differentiation is inhibited by hypoxia leading
to adipocyte hypertrophy without hyperplasia.23
Measurement of VEGF, neoangiogenesis by the CD31
(cluster of differentiation molecule) or PECAM-1 (Platelet
Endothelial Cell Adhesion Molecule) together with morpho-
metric measurements of the adipocyte represent adequate
means to investigate, clarify, and document the increase in
postoperative volume of the omentum flap.24-26
In this project we used laparoscopically harvested
omentum flaps to treat breast deformities, with a significant
volume increase of the omentum over the first months
following its transposition. Our main purpose here was to
establish whether the volume increase of the omentum flap
transposed to the breast region is caused by adipocyte
hypertrophy or hyperplasia. This is the first ‘‘in vivo’’
documentation of the direct effect of neoangiogenesis in
human adipose tissue, as evidenced by modification of
volume observed between two consecutive surgical proce-
dures.
METHODS
In order to assess the nature of the apparent volume
increase of the omentum when transposed to the breast,
eight patients who underwent this procedure were studied.
Variables under Study
Changes in size of the adipocyte were studied by
measuring the perimeter, diameter and area of adipocytes.
The microvascular density was estimated by the counting of
vessels stained by the CD31 endothelial marker and in the
immunohistochemical expression of VEGF.
Study Design
This was an intragroup experiment (within subjects
design) which included omentum samples obtained at the
first and second surgical procedures performed on five
patients with cancer and three with congenital malforma-
tion of the breast. The patients were referred to the clinic for
reconstructive surgery, according to the criteria described
below. The procedures were carried out in hospitals located
in the city of Porto Alegre between 2005 and 2010 and all
were operated on by the same surgical team.
Criteria
The experiment included patients who underwent lapar-
oscopically harvested omentum flap transposition to correct
deformities resulting from the treatment for breast cancer
or congenital deformities of the breast, at two surgical
procedures. The patient’s body mass index (BMI) was stable
between the first and the second surgical procedures,
showing no increase greater than 1 kg/m2. Cases of con-
traindication to laparoscopic procedure, previous abdom-
inal surgery which removed or compromised the viability
of the omentum, previous inflammatory process of the
abdominal cavity, patient refusal to participate in the study,
and variation of BMI greater than 1 kg/m2 between the two
surgical procedures were exclusion criteria.
Surgical Technique
The omentum flap was laparoscopically harvested and
transposed to the region of the deformity of the breast,
pedicled to the Right Gastroepiploic Artery and vein, as
previously described by Costa et al.8,9
In order to mobilize the flap, it was necessary to reduce
significantly the blood supply, allowing flow to run only
through one of the Gastroepiploic Arteries and not through
the short Gastric Arteries, which would have caused
temporary hypoxia.
Omentum samples were obtained at the first surgical
procedure, shortly after its transposition from the abdom-
inal cavity to the breast region, and at the second surgical
procedure during the complementary treatment for breast
symmetrization, at variable times, depending on individual
circumstances such as the will of the patient, her avail-
ability, and the clinical conditions for a second surgical
procedure.
Tissue Samples
Samples measuring one square centimeter were obtained
at the time of the omentum flap transposition to the breast
region and at the time for complementary reconstruction.
Immediately after collection, fragments of tissue were fixed
in 4% buffered formalin solution for 24 hours. The material
was subjected to routine histological processing, immersion
in graded alcohol solutions, clearing in xylene, and paraffin
impregnation. Four-micron-thick sections were stained with
hematoxylin-eosin and morphometric evaluation was con-
ducted. Two additional cuts were collected on slides
previously prepared with organosilane and subjected to
the immunohistochemistry technique, using antibodies
against VEGF (Clone VG1, Dako, Carpinteria, CA, USA)
and CD31 (clone JC70A, Dako, Carpinteria, CA, USA).
The primary antibodies were incubated for twelve hours
at a temperature of 4oC, at dilutions of 1:50 (VEGF) and 1:40
(CD31), followed by the application of the streptavidin
horseradish peroxidase conjugate (LSAB, Dako), and dia-
mino-benzidine tetrahydrochloride (Kit DAB, Dako). A
negative control was obtained by omission of the primary
antibody.
Each of the slides stained with hematoxylin-eosin was
scanned by an experienced pathologist, blinded to clinical
and surgical data, by means of a Zeiss Axiolab microscope,
equipped with a digital camera connected to a computer,
using 10 high-power fields (400X). A morphometric study
was performed using Image Pro Plus software (Media
Cybernetics), and the measurement of the maximum
perimeter and diameter of adipocytes was obtained in
micrometers (mm); the measurement of the area of adipo-
cytes was obtained in square micrometers (mm2). The
corresponding means of each sample for each individual
patient were calculated.
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Microvessel density was obtained by counting vascular
structures stained by CD31 antibody in images captured at
medium magnification (200X), also calculating the corre-
sponding means of each sample for each individual patient.
To study the immunohistochemical expression of VEGF,
the resulting segmented brown color, corresponding to the
Immunohistochemistry VEGF expression was quantified by
VEGF colored pixels per image (pixels/image).
All patients had their BMI observed in the interval
between the first and the second surgery.
Statistical Analysis
The quantitative data obtained in the measurements were
summarized by median values and minimum and max-
imum values. Comparison of procedures 1 and 2 was
performed by nonparametric Wilcoxon test. The level of
significance was 5%. Data were analyzed using SPSS 17.0.
All patients signed an informed consent form and the
project was approved by the Ethics Committee of the
Federal University of Rio Grande do Sul, No. 19749.
RESULTS
Eight patients were included in the study. In all the
patients a visible volume increase of the breast was
observed (Figure 1).
Five of the selected patients were being treated for breast
cancer and three were being treated for benign breast
disease. The average age was 45 (20–60). Table 1 shows
some variability in age, and the difference between the
youngest patient and the oldest patient is practically three
generations. Furthermore, it has been observed that the time
interval between procedures 1 and 2 varied substantially.
The average time interval between the two samples was 192
days (74–320).
Individual BMI was stable during the period between the
first and the second surgical procedure when samples were
collected, and upper individual variation was not greater
than 1 kg/m2 (P = 0.916). Weight gain above this limit was
an exclusion criterion to avoid confusion between omentum
volume increase and weight gain (Table 1).
Table 2 shows a summary of morphometric measure-
ments, vascular density and intensity of VEGF expression
per field. All measurements between surgery 1 and surgery
Figure 1 - On the top, patient with fibrosis and superficial
irregularities of the right breast surface with silicone implant
reconstruction. After transposition of the omentum flap the
visible breast growth is registered in pictures below ( 60th, and
100th post-operative day).
Table 1 - Demographic data and patient statistics (n = 8).
Surgery 1 Surgery 2
Patient Age (years) Height (m) Weight (Kg) BMI (Kg/m2) Weight (Kg) BMI (Kg/m2) Interval* (days)
A 23 1.64 49 18.2 49 18.2 74
B 51 1.55 49 20.4 51 21.2 320
C 55 1.65 60 22.0 59 21.7 162
D 50 1.58 56 22.4 56 22.4 197
E 48 1.59 60 23.7 61 24.1 301
F 60 1.57 62 25.2 61 24.8 140
G 20 1.69 60 21.0 57 20.0 183
H 53 1.51 57 25.0 58 25.4 162
Mean 45 1.60 57 22.2 57 22.2 192
SD 15 0.06 5 2.4 4 2.5 82
Minimum 20 1.51 49 18.2 49 18.2 74
Maximum 60 1.69 62 25.2 61 25.4 320
SD: Standard Deviation, BMI: Body Mass Index.
Comparison between BMI1 x BMI2: P = 0.916
*Between surgical procedures 1 and 2
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Table 2 - Morphometric measurements, vascular density and VEGF of the patients (n = 8).
Perimeter (mm) Diameter (mm) Area (mm2) Vessels (n˚/field) VEGF (Kpixels/field)
Patient 1 2 1 2 1 2 1 2 1 2
A 164 200 49 61 1850 3103 5.5 13.8 96.3 84.7
B 176 188 55 74 2502 4306 6.0 15.5 221.7 156.8
C 193 291 54 92 2308 6201 5.1 16.6 46.3 81.9
D 240 372 74 105 3219 9875 5.0 16.6 89.7 64.4
E 224 298 68 100 3789 6710 5.6 15.2 59.9 41.9
F 230 354 71 109 4019 9207 4.8 16.4 55.2 36.8
G 198 227 60 102 2798 8463 4.6 16.4 109.7 91.4
H 193 384 66 113 3929 10504 5.8 17.4 96.3 49.9
Median 196 295 63 101 3009 7587 5.3 16.4 93.0 73.2
Minimum 164 188 49 61 1850 3103 4.6 13.8 46.3 36.8
maximum 240 384 74 113 4019 10504 6.0 17.4 221.7 156.8
P 0.012 0.012 0.012 0.011 0.093
VEGF: Vascular Endothelial Growth Factor, Kpixels: pixelsX 1000
1: first surgical procedure, 2: second surgical procedure
Figure 2 - Scoter plot with lines showing the variation of the
adipocyte perimeter between surgical procedure 1 and 2. Short
thick lines represent the series median values.
Figure 3 - Scoter plot with lines showing the variation of the
adipocyte diameter between surgical procedure 1 and 2. Short
thick lines represent the series median values.
Figure 4 - Scoter plot with lines showing the variation of the
adipocyte area between surgical procedure 1 and 2. Short thick
lines represent the series median values.
Figure 5 - Scoter plot with lines showing the variation of the
number of vessels between surgical procedure 1 and 2. Short
thick lines represent the series median values.
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2 showed an increase in value. The measurements of peri-
meter (Figure 2), diameter (Figure 3), area (Figure 4) and
vascular density (Figure 5) – increased from the first to the
second sample and reached statistical significance (P #
0.012). VEGF (Figure 6), however, was higher in the first
sample compared with the second, but the reduction did not
reach significance (P ,0.093). One patient had a reverse
result of VEGF, i.e. increased in the second sample, which
can be attributed to biological variability or additional
stimulus not registered by the observer (Table 2 and
Figure 6).
Thus, it can be said that these results indicate an increase
in cell volume (Figure 7A and B) which was consistent
when three different measurements were obtained: peri-
meter, area, and diameter of adipocytes. Moreover, the
increase in the number of vessels in the second sample
(Figure 7C and D) suggests neoangiogenesis stimulated by
the initial increase in VEGF values, as documented in the
first sample.
DISCUSSION
Laparoscopycally harvested omentum flaps were used to
treat breast deformities, with significant volume increases,
which, to the best of our knowledge has never been reported
in any other adipose flap. This volume increase was obser-
ved in all of the patients during the first 3 to 5 months
following transposition. At the moment of the transposition
of the omentum flap to the region of the breast, the adipose
tissue was submitted to a transitory hypoxia, which might
conceivably have stimulated VEGF and, consequently,
neoangiogenesis, leading to the overall increase of the flap
volume. This increase might be attributed to cell prolifera-
tion (adipocyte hyperplasia) or to increased cell size
(adipocyte hypertrophy). It is very probable that the high
initial VEGF was responsible for the observed effect, by
inducing increased vascularization or neoangiogenesis; this
was confirmed by the increased number of vessels per field
in the second sample, similar to what was reported in
rabbits by Zhong et al.22 In Zhong’s study the new vessels
disappeared after three months of observation. We have
observed a maintained increase in vessel density nearly a
year after omentum transposition; this however cannot
be explained by the hypoxia, which was only temporary
Figure 6 - Scoter plot with lines showing the variation of the
VEGF between surgical procedure 1 and 2. Short thick lines
represent the series median values.
Figure 7 - On the top, VEGF immunohistochemical expression shows no noticeable difference between the initial moment (A) and the
second moment (B) (100X original magnification); but the adipocyte sizes are visible bigger in the second moment. In the second line,
CD31 highlights endothelial lining. There are few vessels at the fist moment (C) and more vessels at the second moment (D) (200X
original magnification).
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during the perioperative tempo. No explanation can be
offered for this maintained neovascularization, nor for for
the increased omentum volume in all of these patients. The
analysis of VEGF variation between the samples is marred
by a confounding factor, namely the lack of significance
of the reduction of values between surgery 1 and 2. This
however may have been caused by the punctual case of
patient ‘‘C’’ who exhibited a paradoxical increase in VEGF
value. This case is analyzed in Figure 6.
The difference in time intervals between the first and
second surgeries (74 to 320 days) and the age heterogeneity
of the patients (20 to 60 years) in this study, may be prima
facie interpreted as a limitation of the research; however, it
turned out to be of particular interest for making it possible
to highlight the consistency of the supposed effect of VEGF
stimulation, resulting in neoangiogenesis and hypertrophy
of the adipocytes in all the patients.
According to the Bradford Hill criteria, the important
diversity of ages among patients along with the interval
between the two procedures reinforces the consistency of
the effect of this study because, in spite of the individual
procedural variations, the same effect occurred.27
In this study, evidence showed the extend to which
changes in the tissue microenvironment, by temporary
hypoxia produced by the mobilization of the omentum flap,
are able to produce a cellular response, which in this case is
neoangiogenesis and adipocyte hypertrophy.
CONCLUSION
This study was carried out based on the clinical
observation of the increase in the volume of the omentum
flap which occurred as a spontaneous post-operative
evolution, a phenomenon never before induced ‘‘in-vivo’’
in human beings. It was probably caused by adipocyte
hypertrophy resulting from neoangiogenesis, induced by
increased VEGF resulting from temporary hypoxia. Com-
plementary studies are needed to investigate why neovas-
cularization and omentum volume is maintained for a long
time after the triggering factor stops, a response unlike what
happens in other adipose tissues.
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